COMMUNIQUÉS West-GlobeNewswire

NoorLine launches a free 24 hour Culturally Sensitive online therapy website
05/07/2019
DETROIT, July 05, 2019 (GLOBE NEWSWIRE) -- NoorLine, a free anonymous distress line launches out of Detroit this week to help bring 24 hour peer to peer anonymous emotional support to distressed individuals worldwide. [...]
B.C. youth Samir Dattani to represent Canadians with type 1 diabetes in Washington, D.C.
04/07/2019
Samir will be available for interviews on location from Washington throughout the event (July 8-10) VANCOUVER, British Columbia, July 04, 2019 (GLOBE NEWSWIRE) -- 16-year-old Samir Dattani, a long-time type 1 diabetes [...]
AB Science : Validation of the AB8939 clinical development plan through regulatory authority Scientific Advice procedure
04/07/2019
Paris, July 04, 2019, 7pm Validation of the AB8939 clinical development plan through regulatory authority Scientific Advice procedure AB Science will host a live webcast on 8 July to present the validated clinical plan [...]
AB Science : Validation du plan de développement clinique de la molécule AB8939 suite à la procédure réglementaire de Scientific Advice
04/07/2019
Paris, 4 juillet 2019, 19h Validation du plan de développement clinique de la molécule AB8939 suite à la procédure réglementaire de Scientific Advice AB Science tiendra une conférence web le 8 juillet afin de présenter [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2019
04/07/2019
Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2019 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2019
04/07/2019
Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2019 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Charenton- [...]
Infant Bacterial Therapeutics has recruited the first patient in the pivotal Phase III clinical study
04/07/2019
IBT has recruited the first patient in the Phase III pivotal clinical study, The Connection Study. The development program for IBP-9414, of which The Connection Study is the final planned clinical study, has now been [...]
Ascent Industries Announces That Garett Senez Joins as Vice President Marketing
04/07/2019
VANCOUVER, British Columbia, July 04, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. (CSE: ASNT) ("Ascent") announces Garett Senez is joining the new Management Team to lead Marketing efforts for the company. Garett [...]
Blueberries Announces DTC Eligibility of its Common Shares in the United States
04/07/2019
TORONTO, July 04, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. ( CSE: BBM ) (OTCQB: BBRRF) (FRA: 1OA) (" Blueberries " or the " Company "), a leading Latin American licensed producer of medicinal cannabis and [...]
Algernon Pharmaceuticals Announces Short Form Prospectus Unit Offering
04/07/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, British Columbia, July 04, [...]
Oasmia appoints Business Advisory Board
04/07/2019
Oasmia has appointed a Business Advisory Board with the aim of primarily supporting the commercialization of Apealea and evaluating development and market opportunities for the other product candidates. The members of [...]
Esperite N.V.: announces termination of audit engagement in relation to 2018 annual report
04/07/2019
ESPERITE (ESP) announces termination of audit engagement in relation to 2018 annual report Amsterdam, The Netherlands – 3 July 2019 Esperite N.V. (Euronext: ESP, “ Esperite ”) announces that its statutory auditor, accon [...]
Curetis Group Company Ares Genetics is Granted Key European Patent on Genetic Resistance Testing
04/07/2019
Curetis Group Company Ares Genetics is Granted Key European Patent on Genetic Resistance Testing Patent broadly covers genetic biomarkers and biomarker combinations indicating antibiotic resistance First of eleven [...]
Führende österreichische Klinik, die Klinik Pirawarth, bietet eine medikamentenfreie Behandlung von Patienten mit Depressionen und Schmerzen mit Nexstim SmartFocus TMS an
04/07/2019
Pressemitteilung, Helsinki, 4. Juli 2019 um 9.00 (EET) Führende österreichische Klinik, die Klinik Pirawarth, bietet eine medikamentenfreie Behandlung von Patienten mit Depressionen und Schmerzen mit Nexstim SmartFocus [...]
Bone Therapeutics SA: Transparency notification received from Mr. J. Reymann
04/07/2019
Regulated information Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings Gosselies, Belgium, 4 July 2019, 7am CEST – BONE THERAPEUTICS ( Euronext Brussels and Paris: BOTHE), the [...]
Bone Therapeutics SA : Notification de transparence reçue de la part de M. J. Reymann
04/07/2019
Information réglementée Article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes Gosselies, Belgique, le 4 juillet 2019, 07h00 CEST – BONE THERAPEUTICS (code Euronext [...]
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/07/2019
BURLINGTON, Mass., July 03, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to ten new employees consisting of an aggregate of 29,050 stock options and 5,350 [...]
North Bud Farms Closes Second Tranche of Private Placement Financing
03/07/2019
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, July 03, 2019 (GLOBE NEWSWIRE) -- [...]
Aclaris Therapeutics Announces Appointment of Maxine Gowen to Board of Directors
03/07/2019
WAYNE, Pa., July 03, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory and dermatological diseases, today announced the [...]

Pages